HIF1α expression under normoxia in prostate cancer - Which pathways to target?

Journal of Urology

Volumn 193, Issue 3, 2015, Pages 763-770

  Ranasinghe, Weranja K B ^b   Baldwin, Graham S ^a   Bolton, Damien ^b   Shulkes, Arthur ^a   Ischia, Joseph ^b   Patel, Oneel ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

alpha subunit; anoxia; biological markers; castration resistant; hypoxia inducible factor 1; prostatic neoplasms; up regulation

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; OXYGEN; TUMOR MARKER;

CANCER RADIOTHERAPY; CANCER RESISTANCE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; EXTERNAL BEAM RADIOTHERAPY; GENE AMPLIFICATION; HUMAN; IN VITRO STUDY; METASTASIS; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BIOSYNTHESIS; MALE; METABOLISM; PROSTATIC NEOPLASMS;

HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; OXYGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84922614709     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.10.085     Document Type: Review

References (50)

1. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721
2. G.L. Semenza Hypoxia-inducible factors in physiology and medicine Cell 148 2012 399
3. L. Marignol, M. Coffey, and M. Lawler Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev 34 2008 313
4. G.L. Semenza HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations J Clin Invest 123 2013 3664
5. B. Keith, R.S. Johnson, and M.C. Simon HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression Nat Rev Cancer 12 2011 9
6. D.M. Carnell, R.E. Smith, and F.M. Daley An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance Int J Radiat Oncol Biol Phys 65 2006 91
7. B. Movsas, J.D. Chapman, and A.L. Hanlon Hypoxia in human prostate carcinoma: an Eppendorf PO2 study Am J Clin Oncol 24 2001 458
8. J.S. Rasey, W.J. Koh, and M.L. Evans Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int J Radiat Oncol Biol Phys 36 1996 417
9. C. Parker, M. Milosevic, and A. Toi Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 750
10. R. Garcia-Parra, D. Wood, and R.B. Shah Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques Eur J Nucl Med Mol Imaging 38 2011 1816
11. H. Zhong, G.L. Semenza, and J.W. Simons Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis Cancer Detect Prev 28 2004 88
12. W.K. Ranasinghe, L. Xiao, and S. Kovac The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers PLoS One 8 2013 e54251
13. C.P. Pipinikas, N.D. Carter, and C.M. Corbishley HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer Biomarkers 13 2008 680
14. N. Monsef, M. Soller, and I. Panagopoulos HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation BMC Cancer 10 2010 385
15. K.T. Butterworth, H.O. McCarthy, and A. Devlin Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype Int J Cancer 123 2008 760
16. M.S. Wiesener, H. Turley, and W.E. Allen Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha Blood 92 1998 2260
17. J. Rius, M. Guma, and C. Schachtrup NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha Nature 453 2008 807
18. B.H. Jiang, L.Z. Liu, and R. Schafer A novel role for 3, 4-dichloropropionanilide (DCPA) in the inhibition of prostate cancer cell migration, proliferation, and hypoxia-inducible factor 1alpha expression BMC Cancer 6 2006 204
19. O.R. Saramäki, K.J. Savinainen, and N.N. Nupponen Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer Cancer Genet Cytogenet 128 2001 31
20. C.H. Chau, M.G. Permenter, and S.M. Steinberg Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer Cancer Biol Ther 4 2005 1222
21. M. Koslowski, U. Luxemburger, and O. Türeci Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α Oncogene 30 2011 876
22. E.J. Jacobs, A.W. Hsing, and E.B. Bain Polymorphisms in angiogenesis-related genes and prostate cancer Cancer Epidemiol Biomarkers Prev 17 2008 972
23. J.R. Gnarra, K. Tory, and Y. Weng Mutations of the VHL tumour suppressor gene in renal carcinoma Nat Genet 7 1994 85
24. J. Chen, Y. Wu, and P. Shao Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese DNA Cell Biol 31 2012 790
25. K.J. Lang, A. Kappel, and G.J. Goodall Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia Mol Biol Cell 13 2002 1792
26. R. Karni, Y. Dor, and E. Keshet Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia J Biol Chem 277 2002 42919
27. H. Zhong, K. Chiles, and D. Feldser Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res 60 2000 1541
28. M. Yee Koh, T.R. Spivak-Kroizman, and G. Powis HIF-1 regulation: not so easy come, easy go Trends Biochem Sci 33 2008 526
29. S. Braunstein, K. Karpisheva, and C. Pola A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer Mol Cell 28 2007 501
30. C.L. Kremer, R.R. Klein, and J. Mendelson Expression of mTOR signaling pathway markers in prostate cancer progression Prostate 66 2006 1203
31. V. Kolenko, E. Teper, and A. Kutikov Zinc and zinc transporters in prostate carcinogenesis Nat Rev Urol 10 2013 219
32. S.E. Park, J.W. Park, and Y.S. Cho HIF-1alpha promotes survival of prostate cells at a high zinc environment Prostate 67 2007 1514
33. B.A. Teicher, W.M. Linehan, and L.J. Helman Targeting cancer metabolism Clin Cancer Res 18 2012 5537
34. S. Zhao, Y. Lin, and W. Xu Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 324 2009 261
35. K.K. Singh, M.M. Desouki, and R.B. Franklin Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues Mol Cancer 5 2006 14
36. R. Vergis, C.M. Corbishley, and A.R. Norman Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study Lancet Oncol 9 2008 342
37. A. Fraga, R. Ribeiro, and P. Principe The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration Eur J Cancer 50 2014 359
38. D.C. Weber, J.C. Tille, and C. Combescure The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy Radiat Oncol 7 2012 66
39. J.L. Boddy, S.B. Fox, and C. Han The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clin Cancer Res 11 2005 7658
40. R. Mori, T.B. Dorff, and S. Xiong The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes Prostate 70 2010 1692
41. N.J. Mabjeesh, M.T. Willard, and C.E. Frederickson Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells Clin Cancer Res 9 2003 2416
42. T. Mitani, R. Yamaji, and Y. Higashimura Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment J Steroid Biochem Mol Biol 123 2011 58
43. T. Visakorpi, E. Hyytinen, and P. Koivisto In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat Genet 9 1995 401
44. S. Nanni, V. Benvenuti, and A. Grasselli Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer J Clin Invest 119 2009 1093
45. X.H. Liu, A. Kirschenbaum, and S. Yao Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line Clin Exp Metastasis 17 1999 687
46. E.A. Platz, S. Yegnasubramanian, and J.O. Liu A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment Cancer Discov 1 2011 68
47. H. Zhang, D.Z. Qian, and Y.S. Tan Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc Natl Acad Sci U S A 105 2008 19579
48. Y. Takiyama, T. Harumi, and J. Watanabe Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism Diabetes 60 2011 981
49. D.E. Spratt, C. Zhang, and Z.S. Zumsteg Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality Eur Urol 63 2013 709
50. W.K. Ranasinghe, S. Sengupta, and S. Williams The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer Cancer Med 3 2014 245